Urgent.News

the world's headlines, one feed

Editions

Business

Ceuta Crisis: Spain Issues Ultimatum to Italy - End Border Controls

In view of the migration crisis in Ceuta, Rome had temporarily suspended the Schengen agreement with Madrid. Now Spain is calling for an end to border controls - and is threatening countermeasures.

Translated from German Read in German

Ceuta Crisis: Spain Issues Ultimatum to Italy - End Border Controls

Spain has reportedly issued an ultimatum to Italy's conservative government, demanding the end of border controls introduced due to the Ceuta crisis. According to Spain's official communication, if Italy fails to comply by Sunday, August 9, Madrid may implement proportionate measures to safeguard its citizens' interests and dignity.

Spaniards view these controls as unfair, contrary to EU interests, and discriminatory towards their own population. So far, no response from the Italian government has been confirmed. Italy had suspended the Schengen Agreement, which allows free movement of people within the EU, since last Saturday in response to the migration crisis in Ceuta, Spain's North African enclave.

Approximately 72,000 people from Morocco had entered Ceuta. Italian Prime Minister Giorgia Meloni described the move as an "extraordinary measure" taken to ensure national security and prevent potential repercussions for her country.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

Also reported by 1 other outlet

Read the original at handelsblatt.com →

More in Business

MSS Prepares Ulchi Exercise to Sustain SME Support

The “2026 Ulchi Exercise,” aimed at maintaining government functions and ensuring public safety in the event of a national emergency, will be conducted from Aug. 18 to 21.

  • Ministry of SMEs and Startups prepares for 2026 Ulchi Exercise.
  • Exercise evaluates support for SMEs during national emergencies.
  • Focus on cyberterrorism and Chungmu Plan sustainability.

Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Pre-filled Syringe Across Europe

Samsung Bioepis Co., Ltd. today announced the launch of OPUVIZ™ 40 mg/mL solution in pre-filled syringe (PFS), a biosimilar referencing Eylea1(aflibercept), across Europe, starting today.“We are…

  • Samsung Bioepis launches OPUVIZ™ 40 mg/mL pre-filled syringe in Europe.
  • Vice President Antonio Rito praises convenience and precision of new format.
  • OPUVIZ approved for wet AMD, macular edema, diabetic edema, and choroidal neovascularisation.